The bill would permanently schedule fentanyl-related substances as Schedule I drugs—and impede therapeutic research.* On ...
2d
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback